224 related articles for article (PubMed ID: 19935744)
1. Direct renin inhibition and the kidney.
Hollenberg NK
Nat Rev Nephrol; 2010 Jan; 6(1):49-55. PubMed ID: 19935744
[TBL] [Abstract][Full Text] [Related]
2. [Renin inhibition and the kidney].
Ecder T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
[TBL] [Abstract][Full Text] [Related]
3. [What is renin inhibition? Mechanism of action].
Timurkaynak T
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():5-14. PubMed ID: 20019471
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
Dalla Vestra M; Simioni N; Masiero A
Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
[TBL] [Abstract][Full Text] [Related]
5. Update on role of direct renin inhibitor in diabetic kidney disease.
Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
[TBL] [Abstract][Full Text] [Related]
6. Now that we have a direct renin inhibitor, what should we do with it?
Stanton A
Curr Hypertens Rep; 2008 Jun; 10(3):194-200. PubMed ID: 18765089
[TBL] [Abstract][Full Text] [Related]
7. Renin inhibition in hypertension.
Gradman AH; Kad R
J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
[TBL] [Abstract][Full Text] [Related]
8. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
Sepehrdad R; Frishman WH; Stier CT; Sica DA
Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibition: the holy grail of renin-angiotensin system blockade?
McInnes GT
J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
[No Abstract] [Full Text] [Related]
10. Aliskiren: a new drug for an old problem.
Barrios V; Escobar C
Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):1-10. PubMed ID: 20210772
[TBL] [Abstract][Full Text] [Related]
11. Renin inhibitors in chronic heart failure: the Aliskiren Observation of Heart Failure Treatment study in context.
Krum H; Maggioni A
Clin Cardiol; 2010 Sep; 33(9):536-41. PubMed ID: 20842736
[TBL] [Abstract][Full Text] [Related]
12. Limitations of angiotensin inhibition.
Nobakht N; Kamgar M; Rastogi A; Schrier RW
Nat Rev Nephrol; 2011 Jun; 7(6):356-9. PubMed ID: 21502972
[TBL] [Abstract][Full Text] [Related]
13. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
de la Sierra A; Salazar J
Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
15. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
16. Does direct inhibition bring direct benefit?
Abe S; Taguchi I; Inoue T
Circ J; 2012; 76(6):1326. PubMed ID: 22739081
[No Abstract] [Full Text] [Related]
17. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren and dual therapy in type 2 diabetes mellitus.
Ingelfinger JR
N Engl J Med; 2008 Jun; 358(23):2503-5. PubMed ID: 18525047
[No Abstract] [Full Text] [Related]
19. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
20. [Advantages and limitations of renin inhibition with aliskiren].
Azizi M; Frank M; Steichen O; Blanchard A
Ann Pharm Fr; 2011 May; 69(3):142-50. PubMed ID: 21570538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
